Alnylam Pharmaceuticals Stock Forecast
Recent Alnylam Pharmaceuticals Stock Price | Alnylam Pharmaceuticals Stock Forecast Price | |
$145.16 | +50.81% |
$218.91 |
Recent Alnylam Pharmaceuticals Analyst Ratings Breakdown | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 13 | 13 | 13 | 14 |
Buy ratings: | 3 | 3 | 3 | 3 |
Hold ratings: | 9 | 9 | 9 | 7 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.84 | 1.84 | 1.84 | 1.71 |
The presented Alnylam Pharmaceuticals stock forecast (traded under symbol ALNY), for forward-twelve-months price target as shown at the top of this page, gives you the average Alnylam Pharmaceuticals stock forecast for forward target price for symbol ALNY, across the 22 analysts covering Alnylam Pharmaceuticals (ALNY), as reported in data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Alnylam Pharmaceuticals stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Alnylam Pharmaceuticals stock forecast and half had a lower Alnylam Pharmaceuticals stock forecast) was $216.0 as of 2024-04-19 (which is a different mathematical metric versus taking the average or mean), while the
highest Alnylam Pharmaceuticals stock forecast in the analyst group was $395.0, and the lowest Alnylam Pharmaceuticals stock forecast in the analyst group was
$136.0, with a standard deviation of $53.969. Get the latest Zacks research report on ALNY — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
|
Free ALNY Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (3.16 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |